NEW YORK, NY / ACCESSWIRE / August 29, 2017 / Caleres, Inc. (NYSE: CAL) will be discussing their earnings results in their Q2 Earnings Call to be held August 29, 2017 at 4:30 PM Eastern Time.

To listen to the event live – visit https://www.investornetwork.com/company/3414.

Replay Information

The replay will be available online at https://www.investornetwork.com/company/3414.

About Investor Network

Investor Network (IN) is a new financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 474021

NEW YORK, NY / ACCESSWIRE / August 29, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Tableau Software, Inc. (“Tableau” or the “Company”) (NYSE: DATA) and certain of its officers, on behalf of shareholders who purchased Tableau securities between June 3, 2015 and February 4, 2016, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/data.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that, during the Class Period, Tableau made false and/or misleading statements, and/or failed to disclose that product launches and upgrades by major software competitors were negatively impacting its competitive position and profitability, and, as a result, Tableau’s financial statements were materially false and misleading at all relevant times.

On August 7, 2015, Tableau filed its quarterly report on Form 10-Q restating financial results issued in a July 29, 2015 press release. On February 4, 2016, the Company revealed slowing revenue and in a related earnings call, when the CEO stated that, “the competitive dynamic has become more crowded and difficult.” Following this news, Tableau stock dropped, damaging investors.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/data. or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Tableau, you have until September 26, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 470836

ST. PETERSBURG, FL / ACCESSWIRE / August 29, 2017 / Sylios Corp (OTC PINK: UNGS), a holding company with operations engaged in the exploration and development of oil and natural gas properties, site specific real estate development, holdings in equities, corporate debt and alternative investments is pleased to update shareholders of important dates pertaining to the spin-off of the Company’s wholly owned subsidiary, AMDAQ Corp (f/k/a E 2 Investments, LLC)(the “Subsidiary”).

On August 25, 2017, the Company filed a Notice of Conversion with the State of Florida to effectively convert the Subsidiary from a limited liability company to a Florida for profit corporation. In addition, Articles of Incorporation were filed changing the name of the Subsidiary to AMDAQ Corp. Within the Articles, two classes of stock were designated. The first being Common stock with 250 million shares authorized and the second being Preferred stock with 5 million shares authorized.

The Record Date for the stock dividend is set at September 15, 2017, with a tentative Payment Date of October 2, 2017. The final Payment Date will be determined by the Financial Industry Regulatory Authority (“FINRA”). In order for Sylios shareholders to receive the stock dividend, shareholders must own shares of Sylios Corp as of the close of the Record Date. Sylios Corp’s common stock will begin trading ex-dividend at the open on September 16, 2017.

Shareholders of Sylios Corp entitled to receive the dividend will receive 1 share of AMDAQ common stock for every 750 shares of Sylios Corp common stock owned. In lieu of issuing fractional shares in connection with the stock dividend, the company will round fractional shares up to the next whole share. In a supplemental filing with OTC Markets dated August 28, 2017, the Company incorrectly gave a ratio of 1 share of AMDAQ per 1000 shares of Sylios Corp.

The Company’s transfer agent, Pacific Stock Transfer, will distribute shares of AMDAQ on the Payment Date to certificated shareholders. Shareholders are not required to submit any information to the Company’s transfer agent to receive the newly issued AMDAQ shares of common stock. Pacific Stock Transfer will also act as the transfer agent for AMDAQ.

Shareholders should direct any questions pertaining to the stock dividend to dividend@sylios.com. The Company will establish an information page that will go live tomorrow at the following address http://www.sylios.com/amdaqstockdividend, with details on the transaction.

Business Plan for AMDAQ

AMDAQ’S current operations concentrate around alternative investments through a variety of avenues:

Buying and selling of domestic equities
Purchase of third party debt issued by publicly traded entities
Purchase of mineral rights
Direct Stock Purchase participation with other publicly traded entities
Consulting capacity
Direct funding to small and microcap companies through the issuance of debentures

The Company anticipates updating shareholders on potential acquisitions and new business ventures this week.

About Sylios Corp

Sylios Corp, based in St. Petersburg, FL, is a holding corporation with operations engaged in the exploration and development of oil and natural gas properties, holdings in equities, alternative investments, corporate debt and site-specific real estate development. www.sylios.com

Forward Looking Statements and Disclaimer

Statements made in this press release that express the Company or management’s intentions, plans, beliefs, expectations or predictions of future events, are forward-looking statements. The words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “will” and similar expressions are intended to further identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Those statements are based on many assumptions and are subject to many known and unknown risks, uncertainties and other factors that could cause the Company’s actual activities, results or performance to differ materially from those anticipated or projected in such forward-looking statements. The Company cannot guarantee future financial results; levels of activity, performance or achievements and investors should not place undue reliance on the Company’s forward-looking statements. No information contained in this press release should be construed as any indication whatsoever of the Company’s future financial performance, future revenues or its future stock price. The forward-looking statements contained herein represent the judgment of the Company as of the date of this press release, and the Company expressly disclaims any intent, obligation or undertaking to update or revise such forward-looking statements to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. No information in this press release should be construed as any indication whatsoever of the Company’s future revenues or results of operations. Additional risks and uncertainties are set forth in the Company’s Unaudited Annual Report for the year ended December 31, 2016, which can be found on the OTC Markets website, www.otcmarkets.com.

Contact:

Sylios Corp
(727) 482-1505
info@sylios.com

SOURCE: Sylios Corp

ReleaseID: 474029

NEW YORK, NY / ACCESSWIRE / August 29, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Foundation Medicine, Inc. (“Foundation” or the “Company”) (NASDAQ: FMI) and certain of its officers, on behalf of shareholders who purchased Foundation securities between February 26, 2014 and November 3, 2015, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/fmi.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements, regarding: (1) the reimbursement process and likelihood of coverage for Foundation’s tumor tests by Medicare; and (2) Foundation’s financial guidance. As a result of these false statements, Foundation stock traded at artificially inflated prices throughout the Class Period. Once the true details were made public, the complaint alleges that investors suffered damages.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/fmi, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Foundation, you have until September 26, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 470868

NEW YORK, NY / ACCESSWIRE / August 29, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Tahoe Resources Inc. (“Tahoe” or the “Company”) (NYSE: TAHO) and certain of its officers, on behalf of shareholders who purchased Tahoe securities between April 3, 2013 through July 5, 2017, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/taho.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) consultation obligations relating to the permitting of the Escobal mining license were not met; (2) as a result, the Escobal mining license is subject to suspension; and (3) consequently, Tahoe’s public statements were materially false and misleading at all relevant times.

On July 6, 2017, Tahoe revealed that the Supreme Court of Guatemala issued a provisional decision related to an action brought by CALAS against Guatemala’s Ministry of Energy and Mines (“MEM”) and suspended the Escobal mining license of Minera San Rafael, Tahoe’s subsidiary. CALAS alleges that MEM violated the Xinca Indigenous people’s right of consultation in advance of granting the Escobal mining license. Following this news, Tahoe stock dropped $2.74 per share, or over 32%, to close at $5.56 per share on July 6, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/taho or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Tahoe you have until September 5, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 469503

NEW YORK, NY / ACCESSWIRE / August 29, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Blue Apron Holdings, Inc. (”Blue Apron” or the ”Company”) (NYSE: APRN) securities and certain of its officers, on behalf of a class who purchased Blue Apron securities pursuant to the Registration Statement issued in connection with the Company’s initial public offering (”IPO”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/aprn.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that Defendants made materially false and misleading statements in the Registration Statement and failed to disclose that: (1) rather than continue to significantly increase spending on advertising, Blue Apron had already decided to significantly reduce spending on advertising in Q2 2017, which would hurt sales and profit margins in future quarters; (2) Blue Apron was already experiencing adverse on-time in-full rates, meaning orders were not arriving on time or with all the ingredients needed, which was hurting customer retention; and (3) Blue Apron had run into delays in Q2 2017 with its new factory in Linden, New Jersey.

On August 10, 2017, Blue Apron revealed that it had run into delays with its new factory in Linden, New Jersey, leading to additional delays in new product rollouts, impeding Blue Apron’s ability to gain new customers and maintain current customers. Following this news, Blue Apron stock dropped $1.10 per share or over 17% to close at $5.14 per share on August 10, 2017, a 50% drop from the IPO price.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/aprn or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Blue Apron you have until October 16, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 472968

NEW YORK, NY / ACCESSWIRE / August 29, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against TransDigm Group Incorporated (”TransDigm” or the ”Company”) (NYSE: TDG) and certain of its officers, on behalf of shareholders who purchased TransDigm securities between May 10, 2016 and January 19, 2017, both dates inclusive (the ”Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/tdg.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) TransDigm’s growth and profitability were artificially inflated as a result of its illicit business practices; (2) TransDigm used exclusive distributors to make noncompetitive government bids seems competitive; (3) TransDigm subsidiaries failed to list TransDigm as a parent entity when submitting government bids; and (4) consequently, Defendants’ statements about TransDigm’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

On January 20, 2017, Citron Research issued a report entitled ”Could TransDigm be the Valeant of the Aerospace Industry?” alleging that TransDigm’s business model depended on ”acquir[ing] airplane parts companies (over 50 in total), fir[ing] employees, and egregiously rais[ing] prices,” and suggested that the company’s business model was insufficient for a competitive bidding environment. Following this news, TransDigm stock dropped $24.86 per share, or 9.87%, to close at $226.90 on January 20, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/tdg or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in TransDigm you have until October 10, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 472274